Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Titel:
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Auteur:
Michel, Pierre Boige, Valerie Andre, Thierry Aparicio, Thomas Bachet, Jean Baptiste Dahan, Laetitia Guimbaud, Rosine Lepage, Côme Manfredi, Sylvain Tougeron, David Taieb, Julien Selves, Janick Le Malicot, Karine Di Fiore, Frederic Maillard, Emilie